Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT07601295 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07601295
- Sponsor
- Stanford University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-02-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.